Clinical Scorecard: Creation and assessment of a nomogram for forecasting symptomatic recurrence post-laparoscopic adenomyomectomy
At a Glance
Category
Detail
Condition
Symptomatic recurrence after laparoscopic adenomyomectomy
Key Mechanisms
Independent predictors include previous surgical history of ovarian endometrioma, preoperative CA125 level, concomitant ovarian endometrioma, postoperative medication modality, and duration of postoperative therapy.
Target Population
Women aged 20–45 years with dysmenorrhea and/or menorrhagia undergoing laparoscopic adenomyomectomy.
Care Setting
Department of Gynecology, International Peace Maternity and Child Health Hospital
Key Highlights
Nomogram developed to predict symptomatic recurrence post-surgery.
Study included 484 patients with 131 experiencing recurrence.
Nomogram showed good discriminatory ability (AUC 0.776).
Calibration curve demonstrated good performance.
High net benefit for predicted probability thresholds between 0% and 60%.
Guideline-Based Recommendations
Diagnosis
Ultrasonographic diagnosis of adenomyosis based on MUSA criteria.
Management
Consider adjuvant postoperative hormonal suppression to reduce recurrence.
Monitoring & Follow-up
Postoperative follow-up to assess for symptomatic recurrence.
Risks
Recurrence rates can reach up to 49.0% by the second postoperative year.
Patient & Prescribing Data
Women aged 20–45 years with adenomyosis undergoing laparoscopic adenomyomectomy.
Postoperative hormonal suppression may improve symptom control and reduce recurrence.
Clinical Best Practices
Utilize nomograms for individualized risk estimation post-surgery.
Conduct thorough preoperative evaluations including CA125 levels.
